nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—NR1I2—Barrett's esophagus	0.488	1	CbGaD
Erlotinib—CYP1B1—Omeprazole—Barrett's esophagus	0.127	0.336	CbGbCtD
Erlotinib—ABCG2—Omeprazole—Barrett's esophagus	0.0604	0.16	CbGbCtD
Erlotinib—CYP1A1—Omeprazole—Barrett's esophagus	0.0557	0.148	CbGbCtD
Erlotinib—CYP2C8—Omeprazole—Barrett's esophagus	0.0322	0.0852	CbGbCtD
Erlotinib—CYP1A2—Omeprazole—Barrett's esophagus	0.0249	0.0659	CbGbCtD
Erlotinib—CYP3A4—Esomeprazole—Barrett's esophagus	0.0221	0.0586	CbGbCtD
Erlotinib—ABCB1—Omeprazole—Barrett's esophagus	0.0218	0.0577	CbGbCtD
Erlotinib—CYP2D6—Omeprazole—Barrett's esophagus	0.0205	0.0543	CbGbCtD
Erlotinib—CYP3A4—Omeprazole—Barrett's esophagus	0.013	0.0345	CbGbCtD
Erlotinib—ORM1—bile—Barrett's esophagus	0.00479	0.304	CbGeAlD
Erlotinib—Foetor hepaticus—Omeprazole—Barrett's esophagus	0.00192	0.0224	CcSEcCtD
Erlotinib—Foetor hepaticus—Esomeprazole—Barrett's esophagus	0.00192	0.0224	CcSEcCtD
Erlotinib—NR1I2—digestive system—Barrett's esophagus	0.00171	0.109	CbGeAlD
Erlotinib—Liver disorder—Esomeprazole—Barrett's esophagus	0.00159	0.0186	CcSEcCtD
Erlotinib—Liver disorder—Omeprazole—Barrett's esophagus	0.00159	0.0186	CcSEcCtD
Erlotinib—JAK3—digestive system—Barrett's esophagus	0.00137	0.087	CbGeAlD
Erlotinib—Rigors—Esomeprazole—Barrett's esophagus	0.00133	0.0155	CcSEcCtD
Erlotinib—Rigors—Omeprazole—Barrett's esophagus	0.00133	0.0155	CcSEcCtD
Erlotinib—Proteinuria—Esomeprazole—Barrett's esophagus	0.00124	0.0144	CcSEcCtD
Erlotinib—Proteinuria—Omeprazole—Barrett's esophagus	0.00124	0.0144	CcSEcCtD
Erlotinib—Protein urine present—Esomeprazole—Barrett's esophagus	0.00122	0.0142	CcSEcCtD
Erlotinib—Protein urine present—Omeprazole—Barrett's esophagus	0.00122	0.0142	CcSEcCtD
Erlotinib—Hepatocellular injury—Omeprazole—Barrett's esophagus	0.00109	0.0127	CcSEcCtD
Erlotinib—Hepatocellular injury—Esomeprazole—Barrett's esophagus	0.00109	0.0127	CcSEcCtD
Erlotinib—Melaena—Omeprazole—Barrett's esophagus	0.00106	0.0124	CcSEcCtD
Erlotinib—Melaena—Esomeprazole—Barrett's esophagus	0.00106	0.0124	CcSEcCtD
Erlotinib—Dry eye—Omeprazole—Barrett's esophagus	0.001	0.0117	CcSEcCtD
Erlotinib—Dry eye—Esomeprazole—Barrett's esophagus	0.001	0.0117	CcSEcCtD
Erlotinib—ULK3—digestive system—Barrett's esophagus	0.000932	0.0592	CbGeAlD
Erlotinib—Hepatic failure—Esomeprazole—Barrett's esophagus	0.000878	0.0102	CcSEcCtD
Erlotinib—Hepatic failure—Omeprazole—Barrett's esophagus	0.000878	0.0102	CcSEcCtD
Erlotinib—MKNK1—digestive system—Barrett's esophagus	0.000877	0.0557	CbGeAlD
Erlotinib—Haemolytic anaemia—Omeprazole—Barrett's esophagus	0.000874	0.0102	CcSEcCtD
Erlotinib—Haemolytic anaemia—Esomeprazole—Barrett's esophagus	0.000874	0.0102	CcSEcCtD
Erlotinib—Renal impairment—Omeprazole—Barrett's esophagus	0.000829	0.00968	CcSEcCtD
Erlotinib—Renal impairment—Esomeprazole—Barrett's esophagus	0.000829	0.00968	CcSEcCtD
Erlotinib—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.000789	0.00921	CcSEcCtD
Erlotinib—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.000789	0.00921	CcSEcCtD
Erlotinib—Dry skin—Omeprazole—Barrett's esophagus	0.000723	0.00844	CcSEcCtD
Erlotinib—Dry skin—Esomeprazole—Barrett's esophagus	0.000723	0.00844	CcSEcCtD
Erlotinib—STK10—digestive system—Barrett's esophagus	0.000722	0.0459	CbGeAlD
Erlotinib—Hypokalaemia—Omeprazole—Barrett's esophagus	0.000718	0.00838	CcSEcCtD
Erlotinib—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.000718	0.00838	CcSEcCtD
Erlotinib—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.000711	0.00829	CcSEcCtD
Erlotinib—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.000711	0.00829	CcSEcCtD
Erlotinib—Gastritis—Omeprazole—Barrett's esophagus	0.000698	0.00815	CcSEcCtD
Erlotinib—Gastritis—Esomeprazole—Barrett's esophagus	0.000698	0.00815	CcSEcCtD
Erlotinib—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.000696	0.00812	CcSEcCtD
Erlotinib—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.000696	0.00812	CcSEcCtD
Erlotinib—Dysphagia—Omeprazole—Barrett's esophagus	0.000682	0.00796	CcSEcCtD
Erlotinib—Dysphagia—Esomeprazole—Barrett's esophagus	0.000682	0.00796	CcSEcCtD
Erlotinib—UGT1A1—digestive system—Barrett's esophagus	0.000682	0.0433	CbGeAlD
Erlotinib—Pancreatitis—Omeprazole—Barrett's esophagus	0.000669	0.0078	CcSEcCtD
Erlotinib—Pancreatitis—Esomeprazole—Barrett's esophagus	0.000669	0.0078	CcSEcCtD
Erlotinib—Neutropenia—Esomeprazole—Barrett's esophagus	0.000638	0.00744	CcSEcCtD
Erlotinib—Neutropenia—Omeprazole—Barrett's esophagus	0.000638	0.00744	CcSEcCtD
Erlotinib—ABL1—smooth muscle tissue—Barrett's esophagus	0.00063	0.04	CbGeAlD
Erlotinib—Weight decreased—Esomeprazole—Barrett's esophagus	0.000617	0.0072	CcSEcCtD
Erlotinib—Weight decreased—Omeprazole—Barrett's esophagus	0.000617	0.0072	CcSEcCtD
Erlotinib—Infestation—Esomeprazole—Barrett's esophagus	0.000608	0.0071	CcSEcCtD
Erlotinib—Infestation NOS—Esomeprazole—Barrett's esophagus	0.000608	0.0071	CcSEcCtD
Erlotinib—Infestation—Omeprazole—Barrett's esophagus	0.000608	0.0071	CcSEcCtD
Erlotinib—Infestation NOS—Omeprazole—Barrett's esophagus	0.000608	0.0071	CcSEcCtD
Erlotinib—Depression—Omeprazole—Barrett's esophagus	0.000606	0.00708	CcSEcCtD
Erlotinib—Depression—Esomeprazole—Barrett's esophagus	0.000606	0.00708	CcSEcCtD
Erlotinib—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.000603	0.00704	CcSEcCtD
Erlotinib—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.000603	0.00704	CcSEcCtD
Erlotinib—Renal failure—Esomeprazole—Barrett's esophagus	0.000598	0.00698	CcSEcCtD
Erlotinib—Renal failure—Omeprazole—Barrett's esophagus	0.000598	0.00698	CcSEcCtD
Erlotinib—Stomatitis—Esomeprazole—Barrett's esophagus	0.000593	0.00692	CcSEcCtD
Erlotinib—Stomatitis—Omeprazole—Barrett's esophagus	0.000593	0.00692	CcSEcCtD
Erlotinib—Conjunctivitis—Esomeprazole—Barrett's esophagus	0.000591	0.0069	CcSEcCtD
Erlotinib—Conjunctivitis—Omeprazole—Barrett's esophagus	0.000591	0.0069	CcSEcCtD
Erlotinib—Hepatobiliary disease—Esomeprazole—Barrett's esophagus	0.000575	0.00671	CcSEcCtD
Erlotinib—Hepatobiliary disease—Omeprazole—Barrett's esophagus	0.000575	0.00671	CcSEcCtD
Erlotinib—Epistaxis—Esomeprazole—Barrett's esophagus	0.000574	0.00669	CcSEcCtD
Erlotinib—Epistaxis—Omeprazole—Barrett's esophagus	0.000574	0.00669	CcSEcCtD
Erlotinib—Hepatitis—Omeprazole—Barrett's esophagus	0.000546	0.00637	CcSEcCtD
Erlotinib—Hepatitis—Esomeprazole—Barrett's esophagus	0.000546	0.00637	CcSEcCtD
Erlotinib—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.000539	0.00629	CcSEcCtD
Erlotinib—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.000539	0.00629	CcSEcCtD
Erlotinib—Connective tissue disorder—Esomeprazole—Barrett's esophagus	0.000536	0.00626	CcSEcCtD
Erlotinib—Connective tissue disorder—Omeprazole—Barrett's esophagus	0.000536	0.00626	CcSEcCtD
Erlotinib—Urethral disorder—Omeprazole—Barrett's esophagus	0.000535	0.00625	CcSEcCtD
Erlotinib—Urethral disorder—Esomeprazole—Barrett's esophagus	0.000535	0.00625	CcSEcCtD
Erlotinib—CYP1B1—smooth muscle tissue—Barrett's esophagus	0.000534	0.0339	CbGeAlD
Erlotinib—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000516	0.00602	CcSEcCtD
Erlotinib—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000516	0.00602	CcSEcCtD
Erlotinib—Eye disorder—Esomeprazole—Barrett's esophagus	0.00051	0.00595	CcSEcCtD
Erlotinib—Eye disorder—Omeprazole—Barrett's esophagus	0.00051	0.00595	CcSEcCtD
Erlotinib—SLCO2B1—digestive system—Barrett's esophagus	0.000502	0.0319	CbGeAlD
Erlotinib—ABL1—digestive system—Barrett's esophagus	0.000497	0.0316	CbGeAlD
Erlotinib—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.000492	0.00574	CcSEcCtD
Erlotinib—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.000492	0.00574	CcSEcCtD
Erlotinib—Chills—Esomeprazole—Barrett's esophagus	0.00049	0.00572	CcSEcCtD
Erlotinib—Chills—Omeprazole—Barrett's esophagus	0.00049	0.00572	CcSEcCtD
Erlotinib—Alopecia—Esomeprazole—Barrett's esophagus	0.000482	0.00563	CcSEcCtD
Erlotinib—Alopecia—Omeprazole—Barrett's esophagus	0.000482	0.00563	CcSEcCtD
Erlotinib—Mental disorder—Esomeprazole—Barrett's esophagus	0.000478	0.00558	CcSEcCtD
Erlotinib—Mental disorder—Omeprazole—Barrett's esophagus	0.000478	0.00558	CcSEcCtD
Erlotinib—Malnutrition—Esomeprazole—Barrett's esophagus	0.000475	0.00555	CcSEcCtD
Erlotinib—Malnutrition—Omeprazole—Barrett's esophagus	0.000475	0.00555	CcSEcCtD
Erlotinib—Flatulence—Omeprazole—Barrett's esophagus	0.000468	0.00547	CcSEcCtD
Erlotinib—Flatulence—Esomeprazole—Barrett's esophagus	0.000468	0.00547	CcSEcCtD
Erlotinib—Back pain—Omeprazole—Barrett's esophagus	0.00046	0.00536	CcSEcCtD
Erlotinib—Back pain—Esomeprazole—Barrett's esophagus	0.00046	0.00536	CcSEcCtD
Erlotinib—CYP1B1—digestive system—Barrett's esophagus	0.000421	0.0268	CbGeAlD
Erlotinib—Cough—Omeprazole—Barrett's esophagus	0.000415	0.00484	CcSEcCtD
Erlotinib—Cough—Esomeprazole—Barrett's esophagus	0.000415	0.00484	CcSEcCtD
Erlotinib—Chest pain—Esomeprazole—Barrett's esophagus	0.000405	0.00472	CcSEcCtD
Erlotinib—Myalgia—Esomeprazole—Barrett's esophagus	0.000405	0.00472	CcSEcCtD
Erlotinib—Arthralgia—Omeprazole—Barrett's esophagus	0.000405	0.00472	CcSEcCtD
Erlotinib—Chest pain—Omeprazole—Barrett's esophagus	0.000405	0.00472	CcSEcCtD
Erlotinib—Arthralgia—Esomeprazole—Barrett's esophagus	0.000405	0.00472	CcSEcCtD
Erlotinib—Myalgia—Omeprazole—Barrett's esophagus	0.000405	0.00472	CcSEcCtD
Erlotinib—Anxiety—Esomeprazole—Barrett's esophagus	0.000403	0.00471	CcSEcCtD
Erlotinib—Anxiety—Omeprazole—Barrett's esophagus	0.000403	0.00471	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000402	0.00469	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000402	0.00469	CcSEcCtD
Erlotinib—CYP1A1—epithelium—Barrett's esophagus	0.000391	0.0249	CbGeAlD
Erlotinib—Infection—Omeprazole—Barrett's esophagus	0.000385	0.0045	CcSEcCtD
Erlotinib—Infection—Esomeprazole—Barrett's esophagus	0.000385	0.0045	CcSEcCtD
Erlotinib—Shock—Esomeprazole—Barrett's esophagus	0.000382	0.00445	CcSEcCtD
Erlotinib—Shock—Omeprazole—Barrett's esophagus	0.000382	0.00445	CcSEcCtD
Erlotinib—Nervous system disorder—Esomeprazole—Barrett's esophagus	0.00038	0.00444	CcSEcCtD
Erlotinib—Nervous system disorder—Omeprazole—Barrett's esophagus	0.00038	0.00444	CcSEcCtD
Erlotinib—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.00038	0.00443	CcSEcCtD
Erlotinib—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.00038	0.00443	CcSEcCtD
Erlotinib—Skin disorder—Esomeprazole—Barrett's esophagus	0.000377	0.0044	CcSEcCtD
Erlotinib—Skin disorder—Omeprazole—Barrett's esophagus	0.000377	0.0044	CcSEcCtD
Erlotinib—Anorexia—Esomeprazole—Barrett's esophagus	0.00037	0.00431	CcSEcCtD
Erlotinib—Anorexia—Omeprazole—Barrett's esophagus	0.00037	0.00431	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000353	0.00412	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000353	0.00412	CcSEcCtD
Erlotinib—Insomnia—Esomeprazole—Barrett's esophagus	0.000351	0.00409	CcSEcCtD
Erlotinib—Insomnia—Omeprazole—Barrett's esophagus	0.000351	0.00409	CcSEcCtD
Erlotinib—Dyspnoea—Omeprazole—Barrett's esophagus	0.000346	0.00404	CcSEcCtD
Erlotinib—Dyspnoea—Esomeprazole—Barrett's esophagus	0.000346	0.00404	CcSEcCtD
Erlotinib—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000341	0.00398	CcSEcCtD
Erlotinib—Dyspepsia—Omeprazole—Barrett's esophagus	0.000341	0.00398	CcSEcCtD
Erlotinib—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000337	0.00393	CcSEcCtD
Erlotinib—Decreased appetite—Omeprazole—Barrett's esophagus	0.000337	0.00393	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000335	0.00391	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000335	0.00391	CcSEcCtD
Erlotinib—Fatigue—Esomeprazole—Barrett's esophagus	0.000334	0.0039	CcSEcCtD
Erlotinib—Fatigue—Omeprazole—Barrett's esophagus	0.000334	0.0039	CcSEcCtD
Erlotinib—Pain—Omeprazole—Barrett's esophagus	0.000332	0.00387	CcSEcCtD
Erlotinib—Constipation—Omeprazole—Barrett's esophagus	0.000332	0.00387	CcSEcCtD
Erlotinib—Pain—Esomeprazole—Barrett's esophagus	0.000332	0.00387	CcSEcCtD
Erlotinib—Constipation—Esomeprazole—Barrett's esophagus	0.000332	0.00387	CcSEcCtD
Erlotinib—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000317	0.0037	CcSEcCtD
Erlotinib—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000317	0.0037	CcSEcCtD
Erlotinib—Body temperature increased—Esomeprazole—Barrett's esophagus	0.000307	0.00358	CcSEcCtD
Erlotinib—Abdominal pain—Esomeprazole—Barrett's esophagus	0.000307	0.00358	CcSEcCtD
Erlotinib—Abdominal pain—Omeprazole—Barrett's esophagus	0.000307	0.00358	CcSEcCtD
Erlotinib—Body temperature increased—Omeprazole—Barrett's esophagus	0.000307	0.00358	CcSEcCtD
Erlotinib—CYP1A2—digestive system—Barrett's esophagus	0.000302	0.0192	CbGeAlD
Erlotinib—CYP1A1—digestive system—Barrett's esophagus	0.000298	0.0189	CbGeAlD
Erlotinib—CYP3A5—digestive system—Barrett's esophagus	0.000291	0.0185	CbGeAlD
Erlotinib—Asthenia—Esomeprazole—Barrett's esophagus	0.000278	0.00325	CcSEcCtD
Erlotinib—Asthenia—Omeprazole—Barrett's esophagus	0.000278	0.00325	CcSEcCtD
Erlotinib—Pruritus—Omeprazole—Barrett's esophagus	0.000274	0.0032	CcSEcCtD
Erlotinib—Pruritus—Esomeprazole—Barrett's esophagus	0.000274	0.0032	CcSEcCtD
Erlotinib—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000265	0.0031	CcSEcCtD
Erlotinib—Diarrhoea—Omeprazole—Barrett's esophagus	0.000265	0.0031	CcSEcCtD
Erlotinib—Dizziness—Omeprazole—Barrett's esophagus	0.000256	0.00299	CcSEcCtD
Erlotinib—Dizziness—Esomeprazole—Barrett's esophagus	0.000256	0.00299	CcSEcCtD
Erlotinib—Vomiting—Esomeprazole—Barrett's esophagus	0.000247	0.00288	CcSEcCtD
Erlotinib—Vomiting—Omeprazole—Barrett's esophagus	0.000247	0.00288	CcSEcCtD
Erlotinib—Rash—Omeprazole—Barrett's esophagus	0.000245	0.00285	CcSEcCtD
Erlotinib—Rash—Esomeprazole—Barrett's esophagus	0.000245	0.00285	CcSEcCtD
Erlotinib—Dermatitis—Esomeprazole—Barrett's esophagus	0.000244	0.00285	CcSEcCtD
Erlotinib—Dermatitis—Omeprazole—Barrett's esophagus	0.000244	0.00285	CcSEcCtD
Erlotinib—Headache—Esomeprazole—Barrett's esophagus	0.000243	0.00284	CcSEcCtD
Erlotinib—Headache—Omeprazole—Barrett's esophagus	0.000243	0.00284	CcSEcCtD
Erlotinib—Nausea—Esomeprazole—Barrett's esophagus	0.00023	0.00269	CcSEcCtD
Erlotinib—Nausea—Omeprazole—Barrett's esophagus	0.00023	0.00269	CcSEcCtD
Erlotinib—CYP3A4—digestive system—Barrett's esophagus	0.000219	0.0139	CbGeAlD
Erlotinib—CYP2D6—digestive system—Barrett's esophagus	0.000215	0.0137	CbGeAlD
Erlotinib—ABCB1—epithelium—Barrett's esophagus	0.000203	0.0129	CbGeAlD
Erlotinib—ABCB1—digestive system—Barrett's esophagus	0.000155	0.00982	CbGeAlD
Erlotinib—MAP2K5—Focal Adhesion—HGF—Barrett's esophagus	0.000112	0.00334	CbGpPWpGaD
Erlotinib—CYP3A4—Irinotecan Pathway—APC—Barrett's esophagus	0.000112	0.00333	CbGpPWpGaD
Erlotinib—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—GAST—Barrett's esophagus	0.000111	0.00332	CbGpPWpGaD
Erlotinib—CYP1B1—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000111	0.00331	CbGpPWpGaD
Erlotinib—JAK3—Oncostatin M Signaling Pathway—TP53—Barrett's esophagus	0.000108	0.00324	CbGpPWpGaD
Erlotinib—EGFR—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000108	0.00323	CbGpPWpGaD
Erlotinib—CYP1B1—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.000108	0.00322	CbGpPWpGaD
Erlotinib—ABL1—p53 pathway—CDKN2A—Barrett's esophagus	0.000108	0.00322	CbGpPWpGaD
Erlotinib—CYP1A2—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	0.000107	0.0032	CbGpPWpGaD
Erlotinib—EGFR—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.000105	0.00314	CbGpPWpGaD
Erlotinib—MAP2K5—BDNF signaling pathway—APC—Barrett's esophagus	0.000104	0.00309	CbGpPWpGaD
Erlotinib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26A1—Barrett's esophagus	0.000102	0.00305	CbGpPWpGaD
Erlotinib—CYP1B1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	0.000101	0.00301	CbGpPWpGaD
Erlotinib—CYP3A4—Oxidation by Cytochrome P450—CYP26A1—Barrett's esophagus	0.000101	0.00301	CbGpPWpGaD
Erlotinib—JAK3—Cytokine Signaling in Immune system—HGF—Barrett's esophagus	0.000101	0.003	CbGpPWpGaD
Erlotinib—ABL1—Regulation of retinoblastoma protein—CDKN2A—Barrett's esophagus	9.86e-05	0.00294	CbGpPWpGaD
Erlotinib—CYP3A5—Biological oxidations—CYP26A1—Barrett's esophagus	9.46e-05	0.00282	CbGpPWpGaD
Erlotinib—CYP3A5—Metapathway biotransformation—CYP26A1—Barrett's esophagus	9.33e-05	0.00279	CbGpPWpGaD
Erlotinib—CYP1A1—Biological oxidations—CYP26A1—Barrett's esophagus	8.94e-05	0.00267	CbGpPWpGaD
Erlotinib—CYP1A1—Metapathway biotransformation—CYP26A1—Barrett's esophagus	8.81e-05	0.00263	CbGpPWpGaD
Erlotinib—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	8.59e-05	0.00257	CbGpPWpGaD
Erlotinib—EGFR—Bladder Cancer—TP53—Barrett's esophagus	8.58e-05	0.00256	CbGpPWpGaD
Erlotinib—EGFR—Gastric Cancer Network 2—TP53—Barrett's esophagus	8.58e-05	0.00256	CbGpPWpGaD
Erlotinib—ABL1—Cell Cycle—APC—Barrett's esophagus	8.57e-05	0.00256	CbGpPWpGaD
Erlotinib—EGFR—LPA receptor mediated events—RELA—Barrett's esophagus	8.31e-05	0.00248	CbGpPWpGaD
Erlotinib—CYP3A4—Phase 1 - Functionalization of compounds—CYP26A1—Barrett's esophagus	8.28e-05	0.00247	CbGpPWpGaD
Erlotinib—ABL1—p73 transcription factor network—RELA—Barrett's esophagus	8.22e-05	0.00245	CbGpPWpGaD
Erlotinib—CYP2C8—Biological oxidations—CYP26A1—Barrett's esophagus	8.19e-05	0.00245	CbGpPWpGaD
Erlotinib—ABL1—ATM Signaling Pathway—TP53—Barrett's esophagus	8.19e-05	0.00244	CbGpPWpGaD
Erlotinib—UGT1A1—NRF2 pathway—HGF—Barrett's esophagus	8.15e-05	0.00243	CbGpPWpGaD
Erlotinib—ABL1—DNA Damage Response (only ATM dependent)—APC—Barrett's esophagus	8.13e-05	0.00243	CbGpPWpGaD
Erlotinib—EGFR—AGE/RAGE pathway—RELA—Barrett's esophagus	8.11e-05	0.00242	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—GAST—Barrett's esophagus	8.1e-05	0.00242	CbGpPWpGaD
Erlotinib—MAP2K5—BDNF signaling pathway—RELA—Barrett's esophagus	8.09e-05	0.00242	CbGpPWpGaD
Erlotinib—CYP2C8—Metapathway biotransformation—CYP26A1—Barrett's esophagus	8.08e-05	0.00241	CbGpPWpGaD
Erlotinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—RELA—Barrett's esophagus	8.01e-05	0.00239	CbGpPWpGaD
Erlotinib—EGFR—LPA receptor mediated events—CXCL8—Barrett's esophagus	7.83e-05	0.00234	CbGpPWpGaD
Erlotinib—EGFR—Direct p53 effectors—HGF—Barrett's esophagus	7.66e-05	0.00229	CbGpPWpGaD
Erlotinib—ABCG2—Fluoropyrimidine Activity—TP53—Barrett's esophagus	7.62e-05	0.00227	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—GAST—Barrett's esophagus	7.36e-05	0.0022	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.35e-05	0.0022	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	7.34e-05	0.00219	CbGpPWpGaD
Erlotinib—SLCO2B1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	7.15e-05	0.00214	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways in Glioblastoma—CDKN2A—Barrett's esophagus	7.08e-05	0.00211	CbGpPWpGaD
Erlotinib—ABL1—Cell Cycle—CDKN2A—Barrett's esophagus	6.96e-05	0.00208	CbGpPWpGaD
Erlotinib—ALB—Platelet degranulation—HGF—Barrett's esophagus	6.9e-05	0.00206	CbGpPWpGaD
Erlotinib—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	6.86e-05	0.00205	CbGpPWpGaD
Erlotinib—CYP1A1—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	6.84e-05	0.00204	CbGpPWpGaD
Erlotinib—MKNK1—MAPK Signaling Pathway—TP53—Barrett's esophagus	6.73e-05	0.00201	CbGpPWpGaD
Erlotinib—CYP2D6—Biological oxidations—CYP26A1—Barrett's esophagus	6.73e-05	0.00201	CbGpPWpGaD
Erlotinib—CYP1A1—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	6.64e-05	0.00198	CbGpPWpGaD
Erlotinib—CYP2D6—Metapathway biotransformation—CYP26A1—Barrett's esophagus	6.63e-05	0.00198	CbGpPWpGaD
Erlotinib—ABL2—Developmental Biology—PPARG—Barrett's esophagus	6.63e-05	0.00198	CbGpPWpGaD
Erlotinib—ABL1—DNA Damage Response (only ATM dependent)—CDKN2A—Barrett's esophagus	6.6e-05	0.00197	CbGpPWpGaD
Erlotinib—ALB—Response to elevated platelet cytosolic Ca2+—HGF—Barrett's esophagus	6.57e-05	0.00196	CbGpPWpGaD
Erlotinib—ABL1—ErbB Signaling Pathway—TP53—Barrett's esophagus	6.44e-05	0.00192	CbGpPWpGaD
Erlotinib—EGFR—Androgen receptor signaling pathway—RELA—Barrett's esophagus	6.38e-05	0.00191	CbGpPWpGaD
Erlotinib—MKNK1—Disease—SLC9A1—Barrett's esophagus	6.31e-05	0.00188	CbGpPWpGaD
Erlotinib—JAK3—Hemostasis—HGF—Barrett's esophagus	6.26e-05	0.00187	CbGpPWpGaD
Erlotinib—CYP1A1—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	6.22e-05	0.00186	CbGpPWpGaD
Erlotinib—ABL1—p53 pathway—TP53—Barrett's esophagus	6e-05	0.00179	CbGpPWpGaD
Erlotinib—EGFR—Focal Adhesion—HGF—Barrett's esophagus	6e-05	0.00179	CbGpPWpGaD
Erlotinib—JAK3—Cytokine Signaling in Immune system—RELA—Barrett's esophagus	5.83e-05	0.00174	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—GAST—Barrett's esophagus	5.76e-05	0.00172	CbGpPWpGaD
Erlotinib—ALB—Vitamin B12 Metabolism—RELA—Barrett's esophagus	5.74e-05	0.00171	CbGpPWpGaD
Erlotinib—NR1I2—Generic Transcription Pathway—PPARG—Barrett's esophagus	5.72e-05	0.00171	CbGpPWpGaD
Erlotinib—CYP2C8—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	5.7e-05	0.0017	CbGpPWpGaD
Erlotinib—CYP1A2—Biological oxidations—CYP26A1—Barrett's esophagus	5.7e-05	0.0017	CbGpPWpGaD
Erlotinib—EGFR—Direct p53 effectors—APC—Barrett's esophagus	5.69e-05	0.0017	CbGpPWpGaD
Erlotinib—ABCG2—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	5.67e-05	0.00169	CbGpPWpGaD
Erlotinib—CYP1A2—Metapathway biotransformation—CYP26A1—Barrett's esophagus	5.62e-05	0.00168	CbGpPWpGaD
Erlotinib—EPHA6—Developmental Biology—PPARG—Barrett's esophagus	5.59e-05	0.00167	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—SST—Barrett's esophagus	5.55e-05	0.00166	CbGpPWpGaD
Erlotinib—EGFR—ErbB Signaling Pathway—TP53—Barrett's esophagus	5.51e-05	0.00164	CbGpPWpGaD
Erlotinib—EGFR—Regulation of Actin Cytoskeleton—APC—Barrett's esophagus	5.41e-05	0.00161	CbGpPWpGaD
Erlotinib—ABL2—Developmental Biology—RELA—Barrett's esophagus	5.37e-05	0.0016	CbGpPWpGaD
Erlotinib—ABL1—DNA Damage Response—TP53—Barrett's esophagus	5.36e-05	0.0016	CbGpPWpGaD
Erlotinib—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—Barrett's esophagus	5.29e-05	0.00158	CbGpPWpGaD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	5.19e-05	0.00155	CbGpPWpGaD
Erlotinib—ABL1—miRNA Regulation of DNA Damage Response—TP53—Barrett's esophagus	5.18e-05	0.00154	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—SST—Barrett's esophagus	5.04e-05	0.00151	CbGpPWpGaD
Erlotinib—EGFR—Spinal Cord Injury—PTGS2—Barrett's esophagus	4.95e-05	0.00148	CbGpPWpGaD
Erlotinib—EGFR—Spinal Cord Injury—CXCL8—Barrett's esophagus	4.8e-05	0.00143	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling by NGF—RELA—Barrett's esophagus	4.67e-05	0.0014	CbGpPWpGaD
Erlotinib—ALB—Folate Metabolism—RELA—Barrett's esophagus	4.67e-05	0.00139	CbGpPWpGaD
Erlotinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—TP53—Barrett's esophagus	4.63e-05	0.00138	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	4.53e-05	0.00135	CbGpPWpGaD
Erlotinib—EPHA6—Developmental Biology—RELA—Barrett's esophagus	4.53e-05	0.00135	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	4.43e-05	0.00132	CbGpPWpGaD
Erlotinib—ABL1—Retinoblastoma (RB) in Cancer—TP53—Barrett's esophagus	4.4e-05	0.00131	CbGpPWpGaD
Erlotinib—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	4.4e-05	0.00131	CbGpPWpGaD
Erlotinib—CYP1A2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	4.36e-05	0.0013	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—GAST—Barrett's esophagus	4.35e-05	0.0013	CbGpPWpGaD
Erlotinib—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	4.34e-05	0.00129	CbGpPWpGaD
Erlotinib—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	4.24e-05	0.00126	CbGpPWpGaD
Erlotinib—ALB—SLC-mediated transmembrane transport—SLC9A1—Barrett's esophagus	4.22e-05	0.00126	CbGpPWpGaD
Erlotinib—CYP1A1—PPARA activates gene expression—PPARG—Barrett's esophagus	4.21e-05	0.00126	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	4.15e-05	0.00124	CbGpPWpGaD
Erlotinib—MAP2K5—MAPK Signaling Pathway—TP53—Barrett's esophagus	4.14e-05	0.00124	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	4.13e-05	0.00123	CbGpPWpGaD
Erlotinib—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	4.12e-05	0.00123	CbGpPWpGaD
Erlotinib—CYP1A2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	3.96e-05	0.00118	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—SST—Barrett's esophagus	3.95e-05	0.00118	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways in Glioblastoma—TP53—Barrett's esophagus	3.94e-05	0.00118	CbGpPWpGaD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	3.94e-05	0.00118	CbGpPWpGaD
Erlotinib—ABL1—Cell Cycle—TP53—Barrett's esophagus	3.87e-05	0.00116	CbGpPWpGaD
Erlotinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—RELA—Barrett's esophagus	3.86e-05	0.00115	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—RELA—Barrett's esophagus	3.71e-05	0.00111	CbGpPWpGaD
Erlotinib—EGFR—Fc epsilon receptor (FCERI) signaling—RELA—Barrett's esophagus	3.68e-05	0.0011	CbGpPWpGaD
Erlotinib—ABL1—DNA Damage Response (only ATM dependent)—TP53—Barrett's esophagus	3.67e-05	0.0011	CbGpPWpGaD
Erlotinib—ALB—Selenium Micronutrient Network—PTGS2—Barrett's esophagus	3.61e-05	0.00108	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—GAST—Barrett's esophagus	3.54e-05	0.00106	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PTGES—Barrett's esophagus	3.51e-05	0.00105	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	3.5e-05	0.00104	CbGpPWpGaD
Erlotinib—ABCG2—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	3.48e-05	0.00104	CbGpPWpGaD
Erlotinib—EGFR—B Cell Activation—RELA—Barrett's esophagus	3.41e-05	0.00102	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	3.37e-05	0.00101	CbGpPWpGaD
Erlotinib—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	3.34e-05	0.000997	CbGpPWpGaD
Erlotinib—JAK3—Immune System—HGF—Barrett's esophagus	3.28e-05	0.00098	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PTGES—Barrett's esophagus	3.27e-05	0.000978	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—GAST—Barrett's esophagus	3.22e-05	0.000961	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—HGF—Barrett's esophagus	3.21e-05	0.000957	CbGpPWpGaD
Erlotinib—ABL1—Factors involved in megakaryocyte development and platelet production—TP53—Barrett's esophagus	3.08e-05	0.000919	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	3.07e-05	0.000915	CbGpPWpGaD
Erlotinib—ALB—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	3.06e-05	0.000914	CbGpPWpGaD
Erlotinib—MKNK1—Disease—APC—Barrett's esophagus	2.98e-05	0.000891	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PTGES—Barrett's esophagus	2.98e-05	0.000889	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—SST—Barrett's esophagus	2.98e-05	0.000889	CbGpPWpGaD
Erlotinib—EGFR—Spinal Cord Injury—TP53—Barrett's esophagus	2.95e-05	0.000879	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	2.89e-05	0.000862	CbGpPWpGaD
Erlotinib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	2.84e-05	0.000847	CbGpPWpGaD
Erlotinib—ABL1—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	2.83e-05	0.000845	CbGpPWpGaD
Erlotinib—NR1I2—Gene Expression—PPARG—Barrett's esophagus	2.75e-05	0.000821	CbGpPWpGaD
Erlotinib—ALB—Folate Metabolism—TP53—Barrett's esophagus	2.7e-05	0.000806	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—CYP26A1—Barrett's esophagus	2.66e-05	0.000794	CbGpPWpGaD
Erlotinib—EGFR—Direct p53 effectors—TP53—Barrett's esophagus	2.57e-05	0.000767	CbGpPWpGaD
Erlotinib—EGFR—Signaling by NGF—RELA—Barrett's esophagus	2.51e-05	0.000749	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—CYP26A1—Barrett's esophagus	2.48e-05	0.000741	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—SST—Barrett's esophagus	2.43e-05	0.000725	CbGpPWpGaD
Erlotinib—EGFR—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	2.42e-05	0.000722	CbGpPWpGaD
Erlotinib—ABL1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	2.34e-05	0.0007	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—PPARG—Barrett's esophagus	2.34e-05	0.000699	CbGpPWpGaD
Erlotinib—MKNK1—Disease—PTGS2—Barrett's esophagus	2.27e-05	0.000677	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CYP26A1—Barrett's esophagus	2.26e-05	0.000674	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	2.24e-05	0.000668	CbGpPWpGaD
Erlotinib—EGFR—MAPK Signaling Pathway—TP53—Barrett's esophagus	2.22e-05	0.000663	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—SST—Barrett's esophagus	2.21e-05	0.000659	CbGpPWpGaD
Erlotinib—JAK3—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.16e-05	0.000646	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	2.14e-05	0.00064	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PTGES—Barrett's esophagus	2.13e-05	0.000637	CbGpPWpGaD
Erlotinib—JAK3—Hemostasis—TP53—Barrett's esophagus	2.1e-05	0.000627	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—APC—Barrett's esophagus	2.09e-05	0.000624	CbGpPWpGaD
Erlotinib—EGFR—Disease—SLC9A1—Barrett's esophagus	2.08e-05	0.000621	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PTGES—Barrett's esophagus	2.02e-05	0.000602	CbGpPWpGaD
Erlotinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	2e-05	0.000598	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—PPARG—Barrett's esophagus	2e-05	0.000597	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—CXCL8—Barrett's esophagus	1.96e-05	0.000587	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—SLC9A1—Barrett's esophagus	1.92e-05	0.000573	CbGpPWpGaD
Erlotinib—JAK3—Immune System—RELA—Barrett's esophagus	1.9e-05	0.000569	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—GAST—Barrett's esophagus	1.9e-05	0.000568	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—RELA—Barrett's esophagus	1.9e-05	0.000566	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	1.88e-05	0.000561	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PTGES—Barrett's esophagus	1.85e-05	0.000552	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PTGES—Barrett's esophagus	1.84e-05	0.000549	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.83e-05	0.000547	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—SLC9A1—Barrett's esophagus	1.79e-05	0.000534	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	1.7e-05	0.000507	CbGpPWpGaD
Erlotinib—ABL1—Immune System—HGF—Barrett's esophagus	1.68e-05	0.000502	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—RELA—Barrett's esophagus	1.67e-05	0.0005	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—RELA—Barrett's esophagus	1.63e-05	0.000488	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—SLC9A1—Barrett's esophagus	1.63e-05	0.000486	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—RELA—Barrett's esophagus	1.62e-05	0.000484	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CYP26A1—Barrett's esophagus	1.62e-05	0.000483	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTGES—Barrett's esophagus	1.61e-05	0.000481	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—HGF—Barrett's esophagus	1.58e-05	0.000471	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—APC—Barrett's esophagus	1.58e-05	0.000471	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—CXCL8—Barrett's esophagus	1.54e-05	0.000459	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CYP26A1—Barrett's esophagus	1.53e-05	0.000456	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTGES—Barrett's esophagus	1.52e-05	0.000453	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.44e-05	0.000431	CbGpPWpGaD
Erlotinib—EGFR—Immune System—HGF—Barrett's esophagus	1.44e-05	0.000429	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—RELA—Barrett's esophagus	1.43e-05	0.000427	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CYP26A1—Barrett's esophagus	1.4e-05	0.000418	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CYP26A1—Barrett's esophagus	1.39e-05	0.000416	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—RELA—Barrett's esophagus	1.37e-05	0.00041	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—SST—Barrett's esophagus	1.3e-05	0.000389	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTGES—Barrett's esophagus	1.29e-05	0.000384	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—APC—Barrett's esophagus	1.28e-05	0.000384	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—RELA—Barrett's esophagus	1.23e-05	0.000368	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	1.22e-05	0.000364	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—SLC9A1—Barrett's esophagus	1.17e-05	0.000348	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CXCL8—Barrett's esophagus	1.16e-05	0.000346	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	1.15e-05	0.000343	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.13e-05	0.000337	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—SLC9A1—Barrett's esophagus	1.1e-05	0.000329	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—TP53—Barrett's esophagus	1.08e-05	0.000321	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.04e-05	0.000309	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.03e-05	0.000307	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	1.01e-05	0.000302	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—SLC9A1—Barrett's esophagus	1.01e-05	0.000302	CbGpPWpGaD
Erlotinib—ALB—Metabolism—SLC9A1—Barrett's esophagus	1e-05	0.0003	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—RELA—Barrett's esophagus	1e-05	0.0003	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTGES—Barrett's esophagus	9.92e-06	0.000296	CbGpPWpGaD
Erlotinib—EGFR—Disease—APC—Barrett's esophagus	9.85e-06	0.000294	CbGpPWpGaD
Erlotinib—ABL1—Immune System—RELA—Barrett's esophagus	9.75e-06	0.000291	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CYP26A1—Barrett's esophagus	9.75e-06	0.000291	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CXCL8—Barrett's esophagus	9.46e-06	0.000282	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—TP53—Barrett's esophagus	9.45e-06	0.000282	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	8.88e-06	0.000265	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	8.8e-06	0.000263	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PPARG—Barrett's esophagus	8.76e-06	0.000261	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CXCL8—Barrett's esophagus	8.59e-06	0.000257	CbGpPWpGaD
Erlotinib—EGFR—Immune System—RELA—Barrett's esophagus	8.33e-06	0.000249	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	8.29e-06	0.000248	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PPARG—Barrett's esophagus	8.17e-06	0.000244	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	8.14e-06	0.000243	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	8.1e-06	0.000242	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	7.52e-06	0.000225	CbGpPWpGaD
Erlotinib—EGFR—Disease—PTGS2—Barrett's esophagus	7.48e-06	0.000223	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PPARG—Barrett's esophagus	7.43e-06	0.000222	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	7.2e-06	0.000215	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TP53—Barrett's esophagus	7.12e-06	0.000213	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—SLC9A1—Barrett's esophagus	7.03e-06	0.00021	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—APC—Barrett's esophagus	6.9e-06	0.000206	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PTGS2—Barrett's esophagus	6.89e-06	0.000206	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PTGS2—Barrett's esophagus	6.42e-06	0.000192	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PTGS2—Barrett's esophagus	5.84e-06	0.000174	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TP53—Barrett's esophagus	5.81e-06	0.000173	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	5.66e-06	0.000169	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	5.42e-06	0.000162	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—RELA—Barrett's esophagus	5.39e-06	0.000161	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PPARG—Barrett's esophagus	5.32e-06	0.000159	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—TP53—Barrett's esophagus	5.29e-06	0.000158	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CXCL8—Barrett's esophagus	5.08e-06	0.000152	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PPARG—Barrett's esophagus	5.03e-06	0.00015	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PPARG—Barrett's esophagus	4.61e-06	0.000138	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PPARG—Barrett's esophagus	4.58e-06	0.000137	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PTGS2—Barrett's esophagus	4.19e-06	0.000125	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PPARG—Barrett's esophagus	4.02e-06	0.00012	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PTGS2—Barrett's esophagus	3.96e-06	0.000118	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PPARG—Barrett's esophagus	3.79e-06	0.000113	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PTGS2—Barrett's esophagus	3.63e-06	0.000108	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PTGS2—Barrett's esophagus	3.61e-06	0.000108	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PPARG—Barrett's esophagus	3.21e-06	9.57e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PTGS2—Barrett's esophagus	3.16e-06	9.43e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TP53—Barrett's esophagus	3.12e-06	9.3e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	2.98e-06	8.89e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PTGS2—Barrett's esophagus	2.52e-06	7.53e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PPARG—Barrett's esophagus	2.47e-06	7.39e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	1.95e-06	5.81e-05	CbGpPWpGaD
